ArticleEuropean journal of clinical pharmacology2021
Blinding, pragmatism, and the PRECIS-2 tool for designing and assessing randomized trials.
Merrick Zwarenstein et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it